Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
18 June 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Avid Radiopharmaceuticals Articles
US FDA advisory gives mixed message on Eli Lilly’s brain diagnostic Amyvid NDA
21 January 2011
Eli Lilly to acquire Avid Radiopharma - and Alzheimer’s diagnostic - for up to $800 million
9 November 2010
Showing 1-2 of 2 articles
1
Hot Topics
Most Read
US Supreme Court says patent settlement can "sometimes" be illegal
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
Additional indications in Japan for Roche's Avastin and Astellas' Prograf
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
US Supreme Court says patent settlement can "sometimes" be illegal
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
Additional indications in Japan for Roche's Avastin and Astellas' Prograf
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib